LivingGLP1
Study S002302

Liraglutide in Spinal Fluid

ClinicalTrials.gov record

Registration

Registration
NCT02104037
Acronym
LIRA-CSV
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Status
COMPLETED
Enrollment
8
Start
2012-01
Primary completion
2013-12
Lead sponsor
Mikkel Christensen
Conditions
Liraglutide Blood-brain Transfer
Interventions
PROCEDURE:Lumbar puncture
Results posted
FALSE

Registered primary outcomes

  • cerebrospinal fluid concentration of liraglutide [time 60 minutes]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.